Søndergård et al. [101] conducted a small clinical trial looking at the effects of three weeks of oral GSH supplementation on whole-body insulin sensitivity in obese subjects with (N = 10) and without (N = 10) T2D. The gene discussed is INS; the disease is type 2 diabetes mellitus.